Pregled bibliografske jedinice broj: 493782
Effect on a platelet adhesiveness in diabetics after long term treatment a new oral hypoglycemic agent, gliclazid.
Effect on a platelet adhesiveness in diabetics after long term treatment a new oral hypoglycemic agent, gliclazid. // Current medical research and opinion, 5 (1978), 8; 625-631 doi:10.1185/03007997809110198 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 493782 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Effect on a platelet adhesiveness in diabetics after long term treatment a new oral hypoglycemic agent, gliclazid.
Autori
Rubinjoni, Zdenka ; Turk, Zdenka ; Coce, Frano ; Muštović, D. ; Maitre, D. ; Škrabalo, Zdenko
Izvornik
Current medical research and opinion (0300-7995) 5
(1978), 8;
625-631
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
platelet adhesiveness; diabetes; gliclazid
Sažetak
Gliclazide is an oral hypoglycaemic agent which has been shown in animal models to reduce platelet adhesiveness. In this study, 50 patients with maturity onset diabetes treated with gliclazide (80 mg/day) were followed up for 6 months to 1 year to assess the effect on platelet adhesiveness and control of blood sugar. A significant fall in mean platelet adhesiveness from 29% before treatment to 19.5% after 1 year (p < 0.001) was achieved without any deleterious effect on normal haemostasis. The drug was well tolerated and achieved a satisfactory control of blood sugar levels at the dosages used.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
